Crossmark

Simultaneous Reduction in Both HbA1c and Body Weight with Canagliflozin Versus Glimepiride in Patients with Type 2 Diabetes on Metformin

Published Online: 2016-03-16

Published Print: 2016-06

Authors

Leiter, Lawrence A.

Langslet, Gisle

Vijapurkar, Ujjwala

Davies, Michael J.

Canovatchel, William
Funding

Funding for this research was provided by:

Janssen Research and Development
License Information

Text and Data Mining valid from 2016-03-16
More Information

Article History

Received: 19 January 2016

First Online: 16 March 2016

Document is current